PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

"Early warning signals" as testing demand rises for first time weeks

Thu, 18th Mar 2021 16:18

(Alliance News) - Community demand for coronavirus tests has increased by more than 9% in the last week, the first rise for five weeks, the Health & Safety Executive said.

HSE chief executive Paul Reid said the trend was an "early warning signal" that progress made in bringing down positive case numbers and hospital admissions is stalling.

Reid said there was "some concern" that the daily case numbers are no longer falling as they have been in recent weeks.

He told an HSE briefing on Thursday: "There are early warning signals for us that the brakes are being slightly put on in terms of improvements we've been making over the previous few weeks.

"Because the rate of decrease in hospitalisations for patients with Covid has slowed, particularly over the last few weeks, it's actually stalled.

"And the slowing in reduction of the hospitalised cases mirrors the slowing in reduction of the overall cases happening in the community."

He added: "Community testing demand has increased by over 9% in the past week, community demand for testing has increased for the first time in five weeks.

"That's just one of the early trends, early warning indicators I mentioned earlier on."

In terms of vaccinations however, Reid said the "glass is half full" despite problems with supply and the decision to pause administration of the AstraZeneca inoculation.

The European Medicines Agency is to decide on Thursday whether the AstraZeneca vaccine is safe after its use was paused by a number of European countries, including Ireland.

It followed reports by the Norwegian Medicines Agency of blood clots in a number of patients.

Reid said the decision to pause its use demonstrated the "huge emphasis that we will continuously put on safety of the population".

He added: "Just to reassure, we will respond quickly to whatever decision is recommended, and communicated onwards to us.

"Despite this disappointment we should, in my view, say the glass is half full.

"We have administered around 620,000 vaccinations, and we are witnessing, every day, the collapsing infection rates amongst residents in long-term care facilities, on health care workers and the oldest age groups in the population."

The HSE anticipates that between 70,000 and 75,000 vaccines will be administered next week in the over-70s population.

The health service has now carried out four million coronavirus tests and conducted one million close contact calls.

The seven days up to March 17 saw 3,646 new cases notified, an increase of 6% on the previous week.

Almost 46% of new cases over the past two weeks were among people aged 19 to 44 .

Some 26% of new cases in that period were among children aged 0 to 18 years, and about 8.6% were among people aged 65 years and over.

Reid said: "There are significant signs of stalling in the previously reported progress of cases.

"Numbers of new cases has slightly increased, the reductions in hospitalisations has certainly stalled last week. More positively, the numbers in ICU are reducing."

Over the last 14 days, of the 7,048 new cases notified between March 3 and 16, 6% of them (422) have been admitted to hospital.

Of those, 9% of them were in the age group 0 to 18, with no ICU admissions in that period.

Just over 19% were in the age group 19 to 34 with two ICU admissions.

Almost 33% were in the age group 35 to 64 with four ICU admissions, and around 29% were 65 and over, with seven ICU admissions.

Reid said: "Our hospitals still continue to have significant pressures in relation to Covid and management of Covid.

"We do hope that the progress we have seen in the past few weeks, picks up again in the coming couple of weeks."

On Wednesday, a further 17 deaths of people with coronavirus and another 557 confirmed cases of the virus were notified.

By James Ward, PA

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
13 Feb 2024 12:06

LONDON MARKET MIDDAY: Stocks fall but pound up before US data

(Alliance News) - Stock prices in London were on the decline on Tuesday afternoon, with sentiment tetchy ahead of a US inflation report later.

Read more
13 Feb 2024 09:32

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 09:41

LONDON BROKER RATINGS: Deutsche Bank starts Deliveroo at 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
12 Feb 2024 09:12

Barclays sees "compelling" entry point at AstraZeneca after recent falls

(Sharecast News) - Barclays has kept an 'overweight' position on AstraZeneca despite the biopharma group's disappointing annual results last week, saying that the stock's recent underperformance provides an attractive entry point for investors.

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
9 Feb 2024 07:51

LONDON BRIEFING: Barclays buys Tesco's retail banking business

(Alliance News) - Stocks in London are called to open higher on Friday, closing off a busy corporate week.

Read more
8 Feb 2024 17:00

LONDON MARKET CLOSE: Softer earnings weigh on underperforming FTSE 100

(Alliance News) - London's FTSE 100 ended lower on Thursday, with mixed corporate updates keeping a lid on enthusiasm, while in New York the S&P 500 has the 5,000 point mark in touching distance.

Read more
8 Feb 2024 14:42

London close: Stocks slip as US jobless claims fall

(Sharecast News) - London markets experienced a downturn in trading on Thursday, with stocks relinquishing earlier gains as investors processed a decrease in jobless claims in the United States.

Read more
8 Feb 2024 12:08

LONDON MARKET MIDDAY: DS Smith surges on takeover approach from Mondi

(Alliance News) - Stock prices in London were mixed at midday Thursday, as markets struggled to find direction amid a mixed wave of corporate updates and earnings.

Read more
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.